Skip to main content

Revefenacin Dosage

Medically reviewed by Last updated on Aug 21, 2023.

Applies to the following strengths: 175 mcg/3 mL

Usual Adult Dose for Chronic Obstructive Pulmonary Disease - Maintenance

One 175 mcg vial once a day via a nebulizer with a mouthpiece

Renal Dose Adjustments

No adjustment recommended.

  • Monitor severe renal impairment patients for systemic antimuscarinic adverse effects.

Liver Dose Adjustments

Not recommended with any degree of hepatic impairment.

  • In moderate hepatic impairment, systemic exposure to the drug is unchanged, but exposure to the active metabolite is increased.
  • Safety has not been evaluated in COPD patients with any level of hepatic impairment.



  • Hypersensitivity to any of the ingredients

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:

  • For inhalation via a standard jet nebulizer connected to an air compressor; safety and efficacy have not been established with non-compressor based nebulizer systems.
  • Safety and efficacy have been established with the PARLIC(R) Sprint nebulizer with mouthpiece and the PARI Trek(R) compressor.
  • Only remove the unit dose vial from the pouch immediately before administration.

Storage requirements:
  • Store in protective foil pouch.
  • Store at room temperature; protect from direct sunlight and excessive heat

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.